The settlement resolves a 2013 whistleblower lawsuit, for which the government declined intervention, brought by pharmacist and lawyer Ronald Streck.
Under the Medicaid Drug Rebate Program, drugmakers are required to pay quarterly rebates to state Medicaid programs so that such programs can offer coverage for their products. The rebates are partially based on the average manufacturer prices drugmakers report, which Mr. Streck alleged Bristol Myers Squibb was underreporting so it could pay lower rebates.
The drugmaker will pay about $41 million to the federal government, and the rest will be paid to states participating in the settlement.
More articles on pharmacy:
Walgreens reports strong Q2 results thanks to COVID-19 vaccine rollout
Study: 1 dose of mRNA vaccine may be enough for those previously infected with COVID-19
Pfizer: COVID-19 vaccine effective against South Africa variant
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
